What is Bionano Genomics, Inc. (BNGO)?
Bionano Genomics, Inc. is a life sciences company specializing in genome analysis technology. The company develops and markets platforms designed to detect structural variations and other genomic features that are challenging to identify with traditional sequencing methods. Its technology is used in research and clinical settings to advance understanding of genetic disorders, cancer, and other diseases. Bionano Genomics focuses on providing tools that enable high-resolution genome mapping and analysis. The company supports applications in genomics research, molecular diagnostics, and personalized medicine. It collaborates with academic institutions, biotechnology firms, and healthcare providers to expand the use of its technology. Bionano Genomics is involved in ongoing innovation to improve the accuracy, speed, and accessibility of genome analysis.
Bionano Genomics, Inc. Stock Price Today: Live Overview
The price today is shaped by current session movements, as Bionano Genomics, Inc. trades at $1.1328, experiencing a range from $1.0872 to $1.1172 and a daily percentage change of 0%.
FAQ: Bionano Genomics, Inc. (BNGO)
What is the current price of BNGO stock?
The current price stands at $1.1328.
Does BNGO pay dividends?
Bionano Genomics, Inc. does not currently pay dividends.
Does BNGO have a formal corporate presence or regional headquarters in the UAE?
Bionano Genomics, Inc. operates in the UAE solely through partners and distributors without an official regional office or subsidiary.
What is BNGO best known for?
The company is most famous for its genome analysis and mapping technologies.
What assets are typically shown together with BNGO?
Commonly shown alongside BNGO: Veeva Systems Inc, Clover Health Investments, Koninklijke Philips - ADR
Latest shares articles



